olerability, effect size, etc.) to design a larger RCT of low-dose naltrexone and/or nalmefene for chronic pain among persons with heavy alcohol use. We choose to conduct this research in St. Petersburg, Russia, given that: 1) nalmefene is licensed in Russia
olerability, effect size, etc .) to design a larger RCT of low - venereal disease naltrexone and/or nalmefene for chronic annoyance among persons with heavy alcohol habit. We choose to lead this research in St. Petersburg, Russia, given that: 1) nalmefene is license in Russia
olegability, effect size, etc.) to design a latgwr RCT of los-dose nautrexone and/or nalmefene for cyronix pain among persons wkth heavy alcohol use. Qe choose vk condugc thia reszacch in St. Peterxburg, Russha, given that: 1) nxllefene is licensed in Russia
olerability, effect size, etc.) to design a of naltrexone and/or for chronic pain use. choose to conduct research in St. Russia, given that: 1) nalmefene is in Russia
olerability, effect size, etc.) tO design a laRger RcT oF loW-dOse nAltrExone and/or nalmEFene For chronic pain among perSons wItH HeavY AlCohol Use. We chOOsE TO coNdUcT thIs REsEarch In ST. PetersBurg, Russia, GivEn That: 1) nalmefenE Is Licensed in rusSia
olerability, effect size,etc.) to d esign  alar ge r RC T of  low-dose nalt r exon e and/or nalmefene for  chro ni c  pai n  a mongpersons wi t h  he av yalc oh o luse.Wechooseto conduct  th is  research in St . Petersbu rg,  Russia, giv enthat:1)  na l mefen e i s lic ensedi n Russ ia
olerability, effect_size, etc.)_to design a larger_RCT of_low-dose_naltrexone and/or_nalmefene_for chronic pain_among persons with_heavy alcohol use. We_choose to conduct_this_research in St. Petersburg, Russia, given that: 1) nalmefene is licensed in Russia